research grade glp-1 Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children GLP-2T Dual Agonist Peptide |

E11.65 Type 2 diabetes mellitus with hyperglycemia Use when: The patient has high blood sugar or poor glycemic control, and the provider documents hyperglycemia or poor control. Importance: This code provides stronger payer justification as it shows poor glycemic control

standard obesity coverage eliminated January 1, 2026

Code year: FY2026 (Oct 1 2025 Sep 30 2026) Audience: Certified Coders, Auditors and Clinical Documentation Specialists Access: CCO Members Last updated: April 2026 This Clinical Documentation Guide (CDG) provides AAPC/AHIMA-credentialed coders and CDI specialists with comprehensive guidance for coding obesity, overweight, and body mass index (BMI) conditions under FY2026 ICD-10-CM (effective October 1, 2025 September 30, 2026)

The American Diabetes Association (ADA) uses results of blood tests as the diagnostic criteria